Physician

Amjad M Hammad, MD

According to 2025 Medicare claims, Amjad Hammad, MD (NPI: 1679529234) practices ophthalmology in the Glens Falls, NY market, with the plurality of this provider's patient population coming from Warren, NY. This provider's primary affiliated billing organization is SARATOGA VITREO-RETINAL OPHTHALMOLOGY, PLLC (NPI: 1316055940; TIN: 208260244) and primary practice location at 12020-4105.

Hammad's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 713 traditional Medicare patients, billed 8,105 HCPCS/CPT codes, and received $998,322 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 368 prescription claims across 102 beneficiaries totaling $41,686 in drug costs, led by Bromfenac Sodium (Bromfenac Sodium). Open Payments data shows 4 records totaling $145. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $729,031 to $998,322. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$578K$1.2M2015 Medicare payment: $729,031 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $817,289 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $900,186 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $758,963 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $674,544 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,055,455 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,156,919 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $927,998 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $994,391 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $998,322 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20159466,458$729,031
20161,0666,743$817,289
20171,0196,674$900,186
20187375,475$758,963
20196994,979$674,544
20207426,841$1,055,455
20217167,060$1,156,919
20225525,466$927,998
20236266,557$994,391
20247138,105$998,322

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$33K$65K2015 Drug cost: $30,750 (USD; Tot_Drug_Cst)2016 Drug cost: $42,372 (USD; Tot_Drug_Cst)2017 Drug cost: $37,009 (USD; Tot_Drug_Cst)2018 Drug cost: $47,453 (USD; Tot_Drug_Cst)2019 Drug cost: $65,069 (USD; Tot_Drug_Cst)2020 Drug cost: $55,679 (USD; Tot_Drug_Cst)2021 Drug cost: $50,922 (USD; Tot_Drug_Cst)2022 Drug cost: $36,855 (USD; Tot_Drug_Cst)2023 Drug cost: $36,481 (USD; Tot_Drug_Cst)2024 Drug cost: $41,686 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201599277$30,750
2016150438$42,372
2017115349$37,009
2018109378$47,453
2019107449$65,069
2020130437$55,679
2021117438$50,922
202276276$36,855
202388252$36,481
2024102368$41,686

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system496669$82
67028Injection of drug into eye170917$79
92012Established patient problem focused exam of visual system339980$60
92134Imaging of retina238916$28
92250Photography of the retina391581$25

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Bromfenac SodiumBromfenac Sodium591,548$13,043
LumiganBimatoprost24964$6,730
Prednisolone AcetatePrednisolone Acetate1194,922$5,196
MoxifloxacinMoxifloxacin Hcl72915$1,922
Ketorolac TromethamineKetorolac Tromethamine16416$365

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.4$145Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Amjad M. Hammad, MD?

Tedicare shows public-source Medicare data for Amjad M. Hammad, MD (NPI 1679529234), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amjad M. Hammad, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Amjad M. Hammad, MD?

Amjad M. Hammad, MD is linked to SARATOGA VITREO-RETINAL OPHTHALMOLOGY, PLLC (billing NPI 1316055940) in the available physician profile data.

Does Amjad M. Hammad, MD have Open Payments data?

Amjad M. Hammad, MD has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.